Paclitaxel-eluting balloon plus a bare metal stent vs. sirolimus-eluting stent: IVUS insights in the PEPCAD-III multicenter trial

Nov 16, 2017 by in CARDIOLOGY Comments Off on Paclitaxel-eluting balloon plus a bare metal stent vs. sirolimus-eluting stent: IVUS insights in the PEPCAD-III multicenter trial

Background Restenosis after PCI and/or stent implantation still is one of the challenging problems in the field of interventional cardiology. Different concepts to prevent and to treat restenosis including drug-eluting…

read more

Intravascular ultrasound analysis of lesion severity in patients with acute coronary syndrome or stable angina pectoris

Nov 16, 2017 by in CARDIOLOGY Comments Off on Intravascular ultrasound analysis of lesion severity in patients with acute coronary syndrome or stable angina pectoris

The frequency and distribution of thin-cap fibroatheromas (TCFA) have important clinical implications. We evaluated the frequency and distribution of TCFA identified by virtual histology intravascular ultrasound (VH-IVUS) in acute coronary…

read more

Chronic kidney disease may raise the risk of cardiovascular events by increasing the number of coronary yellow plaques angioscopic study

Nov 16, 2017 by in CARDIOLOGY Comments Off on Chronic kidney disease may raise the risk of cardiovascular events by increasing the number of coronary yellow plaques angioscopic study

Objective The objective was to compare the number of yellow plaques in a coronary artery between patients with and without chronic kidney disease (CKD). Background Chronic kidney disease is an…

read more

High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndrome: a clinicopathological study

Nov 16, 2017 by in CARDIOLOGY Comments Off on High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndrome: a clinicopathological study

Background Systemic levels of myeloperoxidase (MPO) are a marker of inflammation and of plaque vulnerability in patients with acute coronary syndromes (ACS). We assessed the hypothesis that elevations in MPO…

read more

Impact of preoperative total leucocyte count on mortality and cardiovascular complications in patients undergoing nonemergent thoracic aortic surgery

Nov 16, 2017 by in CARDIOLOGY Comments Off on Impact of preoperative total leucocyte count on mortality and cardiovascular complications in patients undergoing nonemergent thoracic aortic surgery

Introduction/Objectives The key role of inflammation in the pathogenesis and progression of atherosclerotic vascular disease is well established, and leucocyte count is a robust marker of inflammation. High preoperative total…

read more

Do patients with severe asymptomatic carotid artery stenosis have a higher risk of stroke and mortality following coronary artery bypass grafting?

Nov 16, 2017 by in CARDIOLOGY Comments Off on Do patients with severe asymptomatic carotid artery stenosis have a higher risk of stroke and mortality following coronary artery bypass grafting?

Background The development of stroke is a major concern in patients undergoing coronary artery bypass grafting (CABG) with concomitant severe carotid artery stenosis (CAS). Whether synchronous carotid revascularization reduces this…

read more

Risk factors and impact of contrast left ventriculogram on incidence of contrast-induced nephropathy: is left ventriculogram really necessary?

Nov 16, 2017 by in CARDIOLOGY Comments Off on Risk factors and impact of contrast left ventriculogram on incidence of contrast-induced nephropathy: is left ventriculogram really necessary?

Introduction Left ventriculogram is a common procedure done in a cardiac catheterization lab to assess and calculate patients’ left ventricle wall motion and function. However, such information can also be…

read more

Femoral vascular complications entail an increased risk of death at 1 year only if there is a significant hematocrit decline associated

Nov 16, 2017 by in CARDIOLOGY Comments Off on Femoral vascular complications entail an increased risk of death at 1 year only if there is a significant hematocrit decline associated

Background A portion of patients (pts) experiencing access-related vascular complications (VCs) do not bleed significantly. The prognosis of these pts with VCs may be different depending on the severity of…

read more
Get Clinical Tree app for offline access